Atlas Trials

Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life

Clinical trial NCT00639301 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT00639301
Sponsor
Memorial Sloan Kettering Cancer Center
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Retinoblastoma
Start date
2008-03-11
Primary completion
2027-03-01
Enrollment
473

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.